Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The Patients
Open Access
- 1 October 2019
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 8139-8149
Abstract
Background: IFIT2 (interferon-induced proteins with tetratricopeptide repeats 2), also known as ISG54, is an important interferon-stimulated gene family protein, which has been confirmed to play a crucial role in anti-cancer as well as anti-virus process. In the present study, we aimed to investigate the IFIT2 expression in human non-small-cell cancer (NSCLC) tissues and its clinical implications. Methods: The immunohistochemistry assay was used to identify the clinical significance and prognostic value of IFIT2 expression in NSCLC tissues. The depletion of IFIT2 was achieved using RNAi approach to assess the role of IFIT2 in the regulation of biological behaviors in human lung cancer cell lines. Results: Decreased IFIT2 expression was found in human NSCLC tissues (both in lung adenocarcinoma and lung squamous cell carcinoma) in contrast to the adjacent normal tissues (both PP=0.027; and in lung squamous cell carcinoma: P=0.029). The Cox model analysis also indicated that the distant metastasis (P=0.043) could be used as an independent prognostic factor for lung adenocarcinoma patients, and the lymph node metastasis (P=0.045) and IFIT2 low expression (P=0.020) could be used as independent prognostic factors for lung squamous cell carcinoma patients. Moreover, the depletion of IFIT2 in human lung cancer cell lines A549, H1975 and SK-MES-1 significantly increased the cellular abilities, such as viability, migration and invasion. Conclusion: Decreased IFIT2 was involved in the initiation and the progression of human NSCLC, and its underlying mechanisms still needs further investigation.Keywords
This publication has 30 references indexed in Scilit:
- Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non‐small cell lung cancer in the National Cancer Data BaseCancer, 2014
- Interferon Induced IFIT Family Genes in Host Antiviral DefenseInternational Journal of Biological Sciences, 2013
- Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinomaWorld Journal of Clinical Oncology, 2013
- Molecular Pathology of Non–Small Cell Lung CancerSurgical Pathology Clinics, 2012
- Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cellsOncogene, 2012
- B7-H4 expression associates with cancer progression and predicts patient’s survival in human esophageal squamous cell carcinomaCancer Immunology, Immunotherapy, 2011
- The Interferon Stimulated Gene 54 Promotes ApoptosisJournal of Biological Chemistry, 2011
- The ISG56/IFIT1 Gene FamilyJournal of Interferon & Cytokine Research, 2011
- IFN-Induced Protein with Tetratricopeptide Repeats 2 Inhibits Migration Activity and Increases Survival of Oral Squamous Cell CarcinomaMolecular Cancer Research, 2008
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002